Characterization of α1-adrenoceptor-mediated contraction in the mouse thoracic aorta

European Journal of Pharmacology

Volumn 424, Issue 2, 2001, Pages 131-140

  Yamamoto, Yoshihisa ^a   Koike, Katsuo ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

1D Adrenoceptor; BMY 7378; Clonidine; Mouse; Thoracic aorta

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BUSPIRONE; CHLOROETHYLCLONIDINE; CLONIDINE; METHOXAMINE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE; 5-METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DIOXANE DERIVATIVE; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN AGONIST;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION; SPECIES DIFFERENCE; THORACIC AORTA; ANIMAL; BIOLOGICAL MODEL; DOSE RESPONSE; IN VITRO STUDY; PHYSIOLOGY; STATISTICS; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; BUSPIRONE; CLONIDINE; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; MALE; METHOXAMINE; MICE; MODELS, BIOLOGICAL; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; SEROTONIN AGONISTS; STATISTICS; VASOCONSTRICTION;

EID: 0035919476     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01134-7     Document Type: Article

References (50)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen
2. Some quantitative uses of drug antagonists
3. 1B-adrenoceptor mediating contraction of the rat spleen
4. International union of pharmacology nomenclature of adrenoceptors
5. 1-adrenoceptors on rabbit aorta
6. 1b-adrenergic receptor
7. 1B-adrenoceptor mediating contraction of the mouse spleen
8. 1-adrenoceptor subtypes A, B, D and L
9. 1 Adrenoceptor classification: Sharpening Occam's razor
10. 1-adrenoceptors in human prostate: Implication for adrenoceptor classification
11. 1-adrenoceptor classification
12. 1c-subtype
13. 1-adrenoceptors
14. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery
15. α- and β-adrenoceptors: From gene to the clinic: 1. Molecular biology and adrenoceptor subclassification
16. 1-adrenoceptors; consensus update
17. 1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery
18. 1-Adrenoceptor subtypes mediating contractions of the rat mesenteric artery
19. The role of alpha 1-adrenoceptors in the clonidine-induced contraction and relaxation of rat aorta
20. The classification of drugs and drug receptors in isolated tissues
21. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline
22. 1A subtype
23. A novel analysis of concentration-dependence of partial agonist. Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors
24. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): Part I. Role of the alpha-1L adrenoceptor in tissue selectivity
25. 2C-adrenoceptor homolog
26. 2A-adrenergic receptor subtype
27. 1 adrenoceptor subtypes
28. 1 Adrenergic receptor subtypes, inositol-phosphates and sources of cell calcium
29. 1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta
30. 1-adrenoceptors in vascular smooth muscle
31. Functional subclassification of vascular α-adrenoceptors
32. 1-adrenoceptor subtypes and two receptor systems in vascular tissues
33. 1-adrenoceptors in mammalian aortae: Subclassification based on chloroethylclonidine, WB4101 and nifedipine
34. A theory of drug action based on the rate of drug-receptor combination
35. The kinetic approach to drug antagonism
36. The margin of safety of neuromuscular transmission
37. Targeted disruption of the mouse beta1-adrenergic receptor gene: Developmental and cardiovascular effects
38. 1D-adrenoceptor antagonist BMY7378 in the rabbit thoracic aorta and illiac artery
39. 1D subtype
40. A modification of receptor theory
41. Targeted disruption of the beta3-adrenergic receptor gene
42. 2+ signaling mechanism and plays a different physiological role
43. 2 and receptor differentiation: A statistical analysis of competitive antagonism
44. Intrinsic activity and effects of guanyl-5′-ylimidophosphate, Gpp(NH)p on the affinity of atrial agonists to the muscarinic receptor
45. Interactions of some partial agonists with beta-adrenoceptor in the isolated Taenia caecum and tracheal smooth muscle of guinea pig
46. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contraction of rat aorta
47. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB216469): Part II. Role of the alpha-1L adrenoceptor in tissue selectivity
48. 1-adrenoceptor antagonists in rat aorta
49. Receptor-reserve and threshold-phenomena: II. Theories on drug-action and a quantitive approach to spare receptors and threshold values
50. 1-Adrenoceptors in the guinea pig thoracic aorta